Vejtorp M, Sørensen S, Ruge S, Vejerslev L O
Department of Gynaecology and Obstetrics, Hvidovre University Hospital, Denmark.
Hum Reprod. 1993 Nov;8(11):1928-32. doi: 10.1093/oxfordjournals.humrep.a137962.
The activity of the corpus luteum, the endometrium and the trophoblast was studied after local medical treatment of 31 women with tubal pregnancy. We measured the serum concentration of progesterone, the secretory endometrial protein placental protein 14 (PP14), and human chorionic gonadotrophin (HCG) before and after treatment by injection of prostaglandin F2 alpha into the site of the gestation and into the corpus luteum. There was no significant difference in the pre-treatment serum progesterone and serum PP14 concentrations of 26 women who were treated successfully and of five women, who were operated on after failure of the treatment. After the prostaglandin treatment the serum progesterone and PP14 concentrations decreased simultaneously with the serum HCG concentration or remained at a low, constant concentration. We conclude that measurement of serum progesterone and PP14 cannot be used for selection of patients for treatment by prostaglandin F2 alpha or for monitoring the effect of the treatment. The injection of prostaglandin into the ovary has either no effect on the activity of the corpus luteum or induces only a partial luteolysis.
对31例输卵管妊娠妇女进行局部药物治疗后,研究了黄体、子宫内膜和滋养层的活性。通过向妊娠部位和黄体注射前列腺素F2α,我们测量了治疗前后血清孕酮、分泌型子宫内膜蛋白胎盘蛋白14(PP14)和人绒毛膜促性腺激素(HCG)的浓度。26例成功治疗的妇女与5例治疗失败后接受手术的妇女,其治疗前血清孕酮和血清PP14浓度无显著差异。前列腺素治疗后,血清孕酮和PP14浓度与血清HCG浓度同时下降,或维持在低水平且恒定。我们得出结论,血清孕酮和PP14的测量不能用于选择接受前列腺素F2α治疗的患者,也不能用于监测治疗效果。向卵巢注射前列腺素对黄体活性要么没有影响,要么仅诱导部分黄体溶解。